Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion

Summary

This trial is for patients with acute occlusion of one of the arteries supplying blood to the leg. The trial is designed to determine the safety and activity of a novel clot dissolving (thrombolytic) drug (alfimeprase).

Timeline

Start

2003-06

Primary completion

—

Completion

—

Publications

• Background Toombs CF. Alfimeprase: pharmacology of a novel fibrinolytic metalloproteinase for thrombolysis. Haemostasis. 2001 May-Dec;31(3-6):141-7. doi: 10.1159/000048057.

Drugs

Indications